Although numerous gene panels have been claimed to be prognostic for early-stage NSCLC tumors (Supplementary Table 5), EPPI gene panel comprising specific ECM molecules has critical biological and clinical significance. This evidence concerns the gene MMRN1 and non-small cell lung carcinoma.